N-Acetyl-β-D-glucosaminidase activity in feral Carcinus maenas exposed to cadmium

Effects of Chemical Compounds on the Activity of the N-acetyl-β-D-Glucosaminidase of the Marine Prawn, Palaemon serratus: Screening In Vitro

N-acetyl-β-D-glucosaminidase (NAGase) is important for crustaceans because the enzyme activity is necessary for the molting process. The present study aimed to assess the sensitivity of Palaemon serratus NAGase activity to a set of compounds of diverse chemical families in the context of in vitro exposures. Compounds representing different chemical families were selected according to their abundance, impact in the environment, and relevance as disruptors of the molting process. In a first step, four solvents (dimethylsulfoxide [DMSO], methanol, acetone, and ethanol) were tested to determine their suitability to dissolve hydrophobic compounds without affecting NAGase activity. Exclusively, ethanol had no effect on enzyme activity and on the integrity of the proteins present in the enzyme extract. The 18 other compounds were tested and four of these compounds, pentoxifylline, fenoxycarb, dithiocarbamate, and RH5849, showed a specific alteration on the activity of NAGase, without affecting the protein content. However, cadmium, zinc, and glyphosate showed a nonspecific alteration, affecting both the enzyme activity and the proteins, whereas ibuprofen exclusively altered the protein content. Finally, 10 of the 22 tested compounds (including DMSO, acetone, and methanol) showed a direct alteration of NAGase activity. Environ Toxicol Chem 2023;42:846-858. © 2023 SETAC.

An assessment of sensitivity biomarkers for urinary cadmium burden

BACKGROUND

Excess cadmium (Cd) intake poses a general risk to health and to the kidneys in particular. Among indices of renal dysfunction under Cd burden measures are the urinary N-acetyl-β-D-glucosidase (UNAG) and urinary β2-microglobulin (Uβ2-MG) enzymes. However, the end-pointed values and the Cd burden threshold remain controversial because the scopes fluctuate widely.

METHODS

To ascertain the clinical benchmark dose of urinary Cd (UCd) burden for renal dysfunction, 1595 residents near a Cd site were surveyed. Urine was sampled and assayed. A benchmark dose low (BMDL) was obtained by fitting UCd levels and index levels.

RESULTS

We found that over 50% of the subjects were suffering from Cd exposure as their UCd levels far exceeded the national standard threshold of 5.000 μg/g creatinine (cr). Further analysis indicated that Uβ2-MG was more sensitive than UNAG for renal dysfunction. The BMDL for UCd was estimated as 3.486 U/g cr (male, where U is unit of enzyme) and 2.998 U/g cr (female) for UNAG. The BMDL for Uβ2-MG, which is released into urine from glomerulus after Cd exposure, was found to be 2.506 μg/g cr (male, where μg is the unit of microglobulin) and 2.236 μg/g cr (female).

CONCLUSIONS

Uβ2-MG is recommended as the sensitivity index for renal dysfunction, with 2.2 μg/g cr as the threshold for clinical diagnosis. Our findings suggest that Uβ2-MG is the better biomarker for exposure to Cd.

Invisible endocrine disruption and its mechanisms: A current review

The research on impacts of environmental chemicals on crustacean molting dates back to the 1970s when ground-breaking studies investigated the disruption of molting in Crustacea by organochlorines. With the emergence of a new scientific inquiry, termed environmental endocrine disruption, in the early 1990s, increasing attention has been attracted to the possibility that environmental chemicals capable of wreaking havoc on sex steroid-regulated processes in vertebrates can also adversely affect ecdysteroid-mediated processes, e.g. molting, in crustaceans. Given the fact that many molting-disrupting chemicals accumulate in crustacean tissues and that the effect on molting is not readily visible in the field, the disruption of molting by environmental chemicals has been dubbed the invisible endocrine disruption. In recent years, much advancement has been made in both the documentation of the phenomenon of molting disruption and the search for mechanisms, by which molting disruption occurs. This review provides an overview of the current status of the field of invisible endocrine disruption, and perspectives on future directions are also presented.